Orthocare Innovations, Oklahoma City, Oklahoma, has been selected to receive R&D Magazine’s R&D 100 award for its Galileo™ system, an instrument that provides clinicians with measurable, objective data to assess the function of persons who utilize prosthetic or orthotic devices. The system combines analytical models and algorithms with Orthocare’s StepWatch™ technology.
“Prosthetics technology has become more advanced, offering persons who have lost limbs the opportunity to return to highly active and productive lives,” Orthocare Innovations CEO Doug McCormack, said. “Payers, however, are increasingly requiring better documentation and objective activity data prior to approving advanced technology devices. Galileo is consistent with the demand for evidence-based practice and will both support clinician decision making and ensure that patients receive appropriate care.”
Now in its 48th year, the R&D 100 awards recognize the 100 most technologically significant products introduced over the past year. Winning products are selected by an independent judging panel and the editors of R&D Magazine. 2010 award recipients also include IBM, Siemens, Intel Corp., and the Massachusetts Institute of Technology’s (MIT) Lincoln Laboratory.
